BastopcuMÖzhanA. The many sides of oxidative stress during coronary artery bypass surgery. Perfusion2021Epub ahead of print, DOI: 10.1177/02676591211024814.
2.
TopcuACBolukcuAOzerenK, et al.Normoxic management of cardiopulmonary bypass reduces myocardial oxidative stress in adult patients undergoing coronary artery bypass graft surgery. Perfusion2021; 36: 261–268.
3.
SmitBSmuldersYMde WaardMC, et al.Moderate hyperoxic versus near-physiological oxygen targets during and after coronary artery bypass surgery: a randomised controlled trial. Crit Care2016; 20: 55.
4.
IhnkenKWinklerASchlensakC, et al.Normoxic cardiopulmonary bypass reduces oxidative myocar- dial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg1998; 116: 327–334.
5.
McGuinnessSPParkeRLDrummondK, et al.A multicenter, randomized, controlled phase IIb trial of avoidance of hyperoxemia during cardiopulmonary bypass. Anesthesiology2016; 125: 465–473.
6.
McCarthyCPRaberIChapmanAR, et al.Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians. JAMA Cardiol2019; 4: 1034–1042.
7.
VermaSFedakPWWeiselRD, et al.Fundamentals of reperfusion injury for the clinical cardiologist. Circulation2002; 105: 2332–2336.
8.
MadhavanSChanSPTanWC, et al.Cardiopulmonary bypass time: every minute counts. J Cardiovasc Surg (Torino)2018; 59: 274–281.
